Diligence memo · auto-generated · as of July 3, 2026

Jackson, Tennessee Hospital Company, LLC

Jackson, Tennessee Hospital Company, LLC looks over-valued against its niche peers and is dormant on financing cadence.

DeprioritizeFinancing has gone silent well past the sector's normal cadence — treat as inactive until outside confirmation of a live operation.

Businessfiled

Jackson, Tennessee Hospital Company, LLC operates in Hospitals and Physicians, based in FRANKLIN.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Jackson, Tennessee Hospital Company, LLC has raised $760K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $760K on 2010-03-01.

Most recent recorded round closed around 2010-03-01.

Valuation (modeled)modeled

Provath models Jackson, Tennessee Hospital Company, LLC at approximately $22M (range $497K–$247M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Over-valued. Modeled value is 1.70× the median modeled value of Pre-Seed Hospitals and Physicians companies in 2010–2012 (46 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Last raise 16.3 yr ago; this sector typically re-raises about every 12 months.

Only one round on record and long silent — often defunct, acquired, or gone quiet.

Comparablesmixed

Capital scale ranks ahead of 29% of Hospitals and Physicians peers (599 compared).

Modeled value ranks above 49% of those peers.

Closest niche peers: SL Denver Leasing, LLC, Livingston Hemodialysis Partners, LLC, Greater Norman Surgery Center LLC, Victory Landmark Real Estate, LLC, Malo Clinic Center for Ambulatory Surgery, LLC.

Peoplefiled

7 named people on file across officers, directors and signatories.

Risks & flagsmixed

Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.

Modeled above niche peers — valuation risk on entry.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.